A multidisciplinary team led by pediatric and fetal surgeon Darrell Cass, MD, performs an EXIT-to-resection procedure, exteriorizing a large, right-sided lung mass in a partially delivered fetus, enabling a safe birth and subsequent removal of the tumor.Read More
In a time of seemingly constant change in healthcare, many different organizations are proposing potential alternate care delivery and payment models, including the ACO. In this article, Maged Rizk, MD, MBA, defines ACOs and describes how the model works.
Safe bedside handoffs are part of Joint Commission National Patient Safety Goals. In 2019, Cleveland Clinic’s Marymount Hospital engaged community members as part of its bedside handoff education efforts with nurses.
There are many unknowns about the risk factors, pathogenesis, prognosis and treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), a Kawasaki-like manifestation of COVID-19 in some children. In this article, pediatric rheumatologists explain that although the condition remains rare, it can be fatal.
This visual tracker of COVID-19 case and mortality data is updated daily to keep you abreast of national and state-by-state trends in the pandemic’s epidemiology.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Blocking a signaling pathway associated with the WISP1 protein may help slow glioblastoma development by disrupting maintenance of glioma stem cells and tumor-supportive macrophages.
Experts make the case for a single-year “interventional intensivist” fellowship that incorporates key skills needed for an interventional cardiologist with those essential for noncardiac critical care.
A new study supports using bivalirudin, a direct thrombin inhibitor, as an alternative to heparin in pediatric ECMO. Pediatric critical care medicine specialist Mohammed Hamzah, MD, discusses his research, as well as the benefits and costs of this treatment.
Patients with COVID-19 who have underlying chronic lung disease are at increased risk for developing severe illness. Pulmonologist Brian Southern, MD, recently authored a review article in Cleveland Clinic Journal of Medicine’s COVID-19 Curbside Consults series. In this article, he takes a closer look at what is known about ILD and sarcoidosis in the context of the pandemic and offers insights for managing care.
Promising results with the novel “compound 3” in early preclinical models of Alzheimer’s disease have paved the way for further preclinical dose and efficacy testing.